222 related articles for article (PubMed ID: 31046673)
1. Increased proteinase 3 and neutrophil elastase plasma concentrations are associated with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes.
Mirea AM; Toonen EJM; van den Munckhof I; Munsterman ID; Tjwa ETTL; Jaeger M; Oosting M; Schraa K; Rutten JHW; van der Graaf M; Riksen NP; de Graaf J; Netea MG; Tack CJ; Chavakis T; Joosten LAB
Mol Med; 2019 May; 25(1):16. PubMed ID: 31046673
[TBL] [Abstract][Full Text] [Related]
2. Increased ratio of neutrophil elastase to α1-antitrypsin is closely associated with liver inflammation in patients with nonalcoholic steatohepatitis.
Zang S; Ma X; Zhuang Z; Liu J; Bian D; Xun Y; Zhang Q; Zhao F; Yang W; Liu J; Luo Y; Liu Y; Ye B; Ye D; Shi J
Clin Exp Pharmacol Physiol; 2016 Jan; 43(1):13-21. PubMed ID: 26444279
[TBL] [Abstract][Full Text] [Related]
3. The relationship of neutrophil elastase and proteinase 3 with risk factors, and chronic complications in type 2 diabetes: A Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) sub-study.
Ong KL; Wu L; Januszewski AS; O'Connell R; Xu A; Scott RS; Sullivan DR; Rye KA; Li H; Ma RC; Li L; Gebski V; Jenkins AJ; Jia W; Keech AC
Diab Vasc Dis Res; 2021; 18(4):14791641211032547. PubMed ID: 34275349
[TBL] [Abstract][Full Text] [Related]
4. Elevated first-trimester neutrophil elastase and proteinase 3 increase the risk of gestational diabetes mellitus and adverse fetal outcomes.
Wang L; Zhou Z; Xu X; Li Y; Zhang R; Yu Z; Huang X; Zang S; Sun T
Reprod Biol Endocrinol; 2024 Jan; 22(1):2. PubMed ID: 38167145
[TBL] [Abstract][Full Text] [Related]
5. Activation of proteinase 3 contributes to Non-alcoholic Fatty Liver Disease (NAFLD) and insulin resistance.
Toonen EJ; Mirea AM; Tack CJ; Stienstra R; Ballak DB; van Diepen JA; Hijmans A; Chavakis T; Dokter WH; Pham CT; Netea MG; Dinarello CA; Joosten LA
Mol Med; 2016 May; 22():202-14. PubMed ID: 27261776
[TBL] [Abstract][Full Text] [Related]
6. Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with β-cell autoimmunity in patients with type 1 diabetes.
Wang Y; Xiao Y; Zhong L; Ye D; Zhang J; Tu Y; Bornstein SR; Zhou Z; Lam KS; Xu A
Diabetes; 2014 Dec; 63(12):4239-48. PubMed ID: 25092677
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity.
Barchetta I; Enhörning S; Cimini FA; Capoccia D; Chiappetta C; Di Cristofano C; Silecchia G; Leonetti F; Melander O; Cavallo MG
BMC Med; 2019 Apr; 17(1):85. PubMed ID: 31035998
[TBL] [Abstract][Full Text] [Related]
8. Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study.
Williams KH; Vieira De Ribeiro AJ; Prakoso E; Veillard AS; Shackel NA; Brooks B; Bu Y; Cavanagh E; Raleigh J; McLennan SV; McCaughan GW; Keane FM; Zekry A; Gorrell MD; Twigg SM
J Diabetes; 2015 Nov; 7(6):809-19. PubMed ID: 25350950
[TBL] [Abstract][Full Text] [Related]
9. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
[TBL] [Abstract][Full Text] [Related]
10. Increased Neutrophil elastase and proteinase 3 are closely associated with occurrence and severity of stroke and acute myocardial infarction in patients with type 2 diabetes mellitus.
Wang L; Pan J; Sun Y; Zong S; Zhang R; Li Y; Yu Z; Liu J; Zang S
Diabetes Res Clin Pract; 2022 Apr; 186():109853. PubMed ID: 35341779
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: results from the WILLOW trial.
Cipolla D; Zhang J; Korkmaz B; Chalmers JD; Basso J; Lasala D; Fernandez C; Teper A; Mange KC; Perkins WR; Sullivan EJ
Respir Res; 2023 May; 24(1):133. PubMed ID: 37198686
[TBL] [Abstract][Full Text] [Related]
12. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
13. NETosis-associated serum biomarkers are reduced in type 1 diabetes in association with neutrophil count.
Qin J; Fu S; Speake C; Greenbaum CJ; Odegard JM
Clin Exp Immunol; 2016 Jun; 184(3):318-22. PubMed ID: 26939803
[TBL] [Abstract][Full Text] [Related]
14. Lean non-alcoholic fatty liver disease and development of diabetes: a cohort study.
Sinn DH; Kang D; Cho SJ; Paik SW; Guallar E; Cho J; Gwak GY
Eur J Endocrinol; 2019 Aug; 181(2):185-192. PubMed ID: 31176297
[TBL] [Abstract][Full Text] [Related]
15. Mice Deficient in the IL-1β Activation Genes Prtn3, Elane, and Casp1 Are Protected Against the Development of Obesity-Induced NAFLD.
Mirea AM; Stienstra R; Kanneganti TD; Tack CJ; Chavakis T; Toonen EJM; Joosten LAB
Inflammation; 2020 Jun; 43(3):1054-1064. PubMed ID: 32002713
[TBL] [Abstract][Full Text] [Related]
16. Increased Plasma Proneurotensin Levels Identify NAFLD in Adults With and Without Type 2 Diabetes.
Barchetta I; Cimini FA; Leonetti F; Capoccia D; Di Cristofano C; Silecchia G; Orho-Melander M; Melander O; Cavallo MG
J Clin Endocrinol Metab; 2018 Jun; 103(6):2253-2260. PubMed ID: 29590379
[TBL] [Abstract][Full Text] [Related]
17. SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy.
Bettini S; Bordigato E; Milan G; Dal Pra' C; Favaretto F; Belligoli A; Sanna M; Serra R; Foletto M; Prevedello L; Busetto L; Fassina G; Vettor R; Fabris R
Obes Facts; 2019; 12(3):291-306. PubMed ID: 31104052
[TBL] [Abstract][Full Text] [Related]
18. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
[TBL] [Abstract][Full Text] [Related]
20. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
